PLA2G7 and diabetes mellitus: Each group had nearly 20% of patients with diabetes mellitus, and 29 (85.3%) patients in normal Lp-PLA2 group and 20 (83.3%) patients in elevated Lp-PLA2 group were treated with insulin and the rest (14.7% vs 16.7%, P = 0.283) were treated with sulfonylureas.